本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Regenxbio Inc

8.19
-0.3200-3.76%
盘后8.190.00000.00%16:10 EDT
成交量:53.95万
成交额:443.47万
市值:4.13亿
市盈率:-2.64
高:8.44
开:8.24
低:8.03
收:8.51
数据加载中...
2024/01/25

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/18

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/02

重要事件披露

Form 8-K - Current report
2023/08/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/06

重要事件披露

Form 8-K - Current report
2023/05/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/05/03

重要事件披露

8-K - Current report
2023/05/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals